Breast cancer screening made the list of 26 Medicaid quality measures that states may begin reporting to the Centers for Medicare and Medicaid Services next year. Measurements excluded other forms of diagnostic imaging.
CMS developed the measures along with the Agency for Healthcare Research and Quality and feedback through public comments. While reporting is voluntary, the agency expects states to take advantage of opportunities to improve.
Those that report should be better able to measure their own performance and deliver better care. “These core set measures will support HHS and its State partners in developing a quality-driven, evidence-based, national system for measuring the quality of health care provided to Medicaid-eligible adults,” according to the recent notice in the federal register.
The measurements were developed as part of the Affordable Care Act and will be reported by states as well as insurance companies that contract to manage Medicaid enrollees.